Journal of Gastrointestinal Surgery

, Volume 16, Issue 9, pp 1651–1652 | Cite as

Personalized Medicine in Pancreatic Cancer: Prognosis and Potential Implications for Therapy

SSAT State-of-the-Art Conference

References

  1. 1.
    Jemal, A., et al. Cancer statistics, 2010. CA: A Cancer Journal for Clinicians 2010; 60(5):277–300.CrossRefGoogle Scholar
  2. 2.
    Stathis, A., et al. Advanced pancreatic carcinoma: current treatment and future challenges. Nat Rev Clin Oncol 2010; 7(3):163–72.PubMedCrossRefGoogle Scholar
  3. 3.
    Yachida, S., et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 2010; 467(7319):1114–7.PubMedCrossRefGoogle Scholar
  4. 4.
    Goggins, M. Identifying molecular markers for the early detection of pancreatic neoplasia. Seminars in oncology 2007; 34(4):303–10.PubMedCrossRefGoogle Scholar
  5. 5.
    Embuscado, E.E., et al. Immortalizing the complexity of cancer metastasis: Genetic features of lethal metastatic pancreatic cancer obtained from rapid autopsy. Cancer Biology & Therapy 2005; 4(5):548–54.CrossRefGoogle Scholar
  6. 6.
    Iacobuzio-Donahue, C.A., et al. Dpc4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer. J Clin Oncol 2009; 27(11):1806–13.PubMedCrossRefGoogle Scholar
  7. 7.
    Wilentz, R.E., et al. Immunohistochemical labeling for dpc4 mirrors genetic status in pancreatic adenocarcinomas: a new marker of dpc4 inactivation. The American Journal of Pathology 2000; 156(1):37–43.PubMedCrossRefGoogle Scholar
  8. 8.
    Blackford, A., et al. Smad4 gene mutations are associated with poor prognosis in pancreatic cancer. Clin Cancer Res 2009; 15(14):4674–9.PubMedCrossRefGoogle Scholar
  9. 9.
    Massague, J. Tgfbeta in cancer. Cell 2008; 134(2):215–30.PubMedCrossRefGoogle Scholar
  10. 10.
    Dai, J.L., et al. G1 cell cycle arrest and apoptosis induction by nuclear smad4/dpc4: phenotypes reversed by a tumorigenic mutation. Proceedings of the National Academy of Sciences of the United States of America 1999; 96(4):1427–32.PubMedCrossRefGoogle Scholar
  11. 11.
    Dai, J.L., et al. Transforming growth factor-beta responsiveness in dpc4/smad4-null cancer cells. Molecular Carcinogenesis 1999; 26(1):37–43.PubMedCrossRefGoogle Scholar
  12. 12.
    Yue, J., et al. Activation of the mitogen-activated protein kinase pathway by transforming growth factor-beta. Methods in Molecular Biology (Clifton, NJ) 2000; 142:125–31.Google Scholar
  13. 13.
    Yu, L., et al. Tgf-beta receptor-activated p38 map kinase mediates smad-independent tgf-beta responses. The EMBO Journal 2002; 21(14):3749–59.PubMedCrossRefGoogle Scholar
  14. 14.
    Derynck, R., et al. Smad-dependent and smad-independent pathways in tgf-beta family signalling. Nature 2003; 425(6958):577–84.PubMedCrossRefGoogle Scholar
  15. 15.
    Moustakas, A., et al. Non-smad tgf-beta signals. Journal of Cell Science 2005; 118(Pt 16):3573–84.PubMedCrossRefGoogle Scholar
  16. 16.
    Bakin, A.V., et al. Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration. The Journal of Biological Chemistry 2000; 275(47):36803–10.PubMedCrossRefGoogle Scholar
  17. 17.
    Gordon, K.J., et al. Loss of type iii transforming growth factor beta receptor expression increases motility and invasiveness associated with epithelial to mesenchymal transition during pancreatic cancer progression. Carcinogenesis 2008; 29(2):252–62.PubMedCrossRefGoogle Scholar
  18. 18.
    Jungert, K., et al. Sp1 is required for transforming growth factor-beta-induced mesenchymal transition and migration in pancreatic cancer cells. Cancer Res 2007; 67(4):1563–70.PubMedCrossRefGoogle Scholar
  19. 19.
    Kern, S.E., et al. The complexity of pancreatic ductal cancers and multidimensional strategies for therapeutic targeting. The Journal of Pathology; 223(2):295–306.Google Scholar
  20. 20.
    Ko, A.H., et al. Radiation therapy in operable and locally advanced pancreatic cancer. J Natl Compr Canc Netw 2010; 8(9):1022–31.PubMedGoogle Scholar
  21. 21.
    Gutt, R., et al. The role of radiotherapy in locally advanced pancreatic carcinoma. Nat Rev Gastroenterol Hepatol 2010; 7(8):437–47.PubMedCrossRefGoogle Scholar

Copyright information

© The Society for Surgery of the Alimentary Tract 2012

Authors and Affiliations

  1. 1.Departments of Pathology, Oncology and Surgery, The Sol Goldman Pancreatic Cancer Research CenterJohns Hopkins Medical InstitutionsBaltimoreUSA
  2. 2.Department of PathologyGI/Liver DivisionBaltimoreUSA

Personalised recommendations